NICE recommends targeted treatment for neuroendocrine cancer in the liver
Posted:
People with neuroendocrine tumours (NETs) in the liver could benefit from a therapy that targets tumours with radiation while limiting exposure to healthy surrounding tissue, according to new guidance from the National Institute for Health and Care Excellence (NICE). NETs are cancers of neuroendocrine cells commonly spread from organs such as the gastrointestinal tract or pancreas to the liver. The guidance is significant as it offers another option for healthcare professionals to treat patients within the National Health Service in England and Wales.
Healthcare is increasingly recognising that wellbeing extends beyond the treatment of illness. Alongside advances in medicine and digital health, there is growing appreciation for the role that everyday self-care plays in supporting physical health, emotional wellbeing and confidence.
From nutrition…
As healthcare systems continue to evolve, technology is playing an increasingly important role in improving patient outcomes, supporting healthcare professionals and creating more efficient models of care. From artificial intelligence and robotics to advanced medical devices and digital health solutions,…
Attendees
Sponsors and Exhibitors
Contact us